According to the latest report by IMARC Group, titled “Equine Healthcare Market by Product (Drugs, Vaccines, Medicated Feed Additives, Diagnostics, and Others), Indication (Musculoskeletal Disorders, Parasite Control, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Rabies, and Others), Distribution Channel (Veterinary Hospitals and Clinics, Retail Pharmacies and Drug Stores), and Region 2025-2033,” the global equine healthcare market size reached USD 1.6 Billion in 2024. Equine healthcare refers to the comprehensive medical and wellness care provided to horses, ponies, donkeys, and mules. It is a specialized field within veterinary medicine that focuses on the unique needs and physiology of these animals. It requires a collaborative effort from veterinarians, farriers, nutritionists, and owners to ensure that animals receive the required comprehensive treatment. It encompasses a wide range of services, which include preventive measures, such as vaccinations and deworming, and the treatment of illnesses and injuries. It also involves nutrition management, dental care, and hoof maintenance to keep the animal in optimal condition. Besides this, it employs several personalized cares for breeding, gestation, and foaling to ensure a healthy pregnancy and delivery.
Global Equine Healthcare Market Trends:
The increasing awareness and education about the importance of specialized care for horses and other equine animals represents one of the key factors positively influencing the market. Additionally, inflating disposable income levels of individuals is enabling them to invest in high-quality healthcare for their equine animals. Apart from this, continuous innovations in diagnostic equipment, such as digital radiography and ultrasound machines, are making it easier and more efficient to diagnose and treat equine illnesses and injuries. Moreover, the rising popularity of equestrian sports and activities is resulting in the increasing spending on equine healthcare, as owners aim to optimize the performance and well-being of their animals. Looking forward, the market value is projected to reach USD 2.6 Billion by 2033, expanding at a CAGR of 5.31% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Products Covered |
|
Indications Covered | Musculoskeletal Disorders, Parasite Control, Equine Herpes Virus, Equine Encephalomyelitis, Equine Influenza, West Nile Virus, Tetanus, Rabies, Others |
Distribution Channels Covered | Veterinary Hospitals and Clinics, Retail Pharmacies and Drug Stores |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Boehringer Ingelheim International GmbH, Ceva, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Esaote SpA, Hallmarq Veterinary Imaging, IDEXX Laboratories Inc., Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800